EMORY UNIVERSITY Diversified Active

Location: Atlanta, GA

CIK: 0001377635 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value: $142M (100.0% shares, 0.0% debt)

Holdings (46)

BRK/A BERKSHIRE HATHAWAY INC DEL 26.2%
Value $37.25M Shares 117 Est. Cost $230816.08 Unrealized +34.7%
JD JD COM INC 8.5%
Value $12.04M Shares 397,528 Est. Cost $39.72 Unrealized
ARRAY BIOPHARMA INC 2.8%
Value $4.011M Shares 86,567 Est. Cost $46.33 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 2.3%
Value $3.213M Shares 131,041 Est. Cost $13.36 Unrealized +12.7%
MIRATI THERAPEUTICS INC 2.2%
Value $3.16M Shares 30,680 Est. Cost $103.00 Unrealized
RA PHARMACEUTICALS INC 2.1%
Value $2.944M Shares 97,916 Est. Cost $18.20 Unrealized
ZOGENIX INC 2.0%
Value $2.862M Shares 59,905 Est. Cost $27.45 Unrealized
EIDOS THERAPEUTICS INC 1.8%
Value $2.606M Shares 83,836 Est. Cost $31.08 Unrealized
BLUEPRINT MEDICINES CORP 1.8%
Value $2.599M Shares 27,551 Est. Cost $94.33 Unrealized
MGTX MEIRAGTX HOLDINGS PLC 1.8%
Value $2.566M Shares 95,462 Est. Cost $20.65 Unrealized 0.0%
AMARIN CORP PLC 1.8%
Value $2.564M Shares 132,255 Est. Cost $13.91 Unrealized
GENOMIC HEALTH INC 1.8%
Value $2.499M Shares 42,966 Est. Cost $39.55 Unrealized
RETROPHIN INC 1.7%
Value $2.483M Shares 123,600 Est. Cost $26.95 Unrealized
WVE WAVE LIFE SCIENCES LTD 1.7%
Value $2.465M Shares 94,475 Est. Cost $32.02 Unrealized -12.4%
NBIX NEUROCRINE BIOSCIENCES INC 1.7%
Value $2.45M Shares 29,020 Est. Cost $61.50 Unrealized +33.5%
BCRX BIOCRYST PHARMACEUTICALS 1.7%
Value $2.447M Shares 645,583 Est. Cost $6.74 Unrealized -10.7%
INCY INCYTE CORP 1.7%
Value $2.44M Shares 28,714 Est. Cost $87.45 Unrealized -8.2%
MDGL MADRIGAL PHARMACEUTICALS INC 1.7%
Value $2.424M Shares 23,131 Est. Cost $190.01 Unrealized -43.6%
ACAD ACADIA PHARMACEUTICALS INC 1.7%
Value $2.411M Shares 90,188 Est. Cost $22.87 Unrealized +11.7%
FOLD AMICUS THERAPEUTICS INC 1.7%
Value $2.403M Shares 192,533 Est. Cost $10.42 Unrealized +21.7%
HRTX HERON THERAPEUTICS INC 1.7%
Value $2.398M Shares 129,020 Est. Cost $27.34 Unrealized -26.9%
ALEXION PHARMACEUTICALS INC 1.7%
Value $2.388M Shares 18,235 Est. Cost $134.42 Unrealized
SEATTLE GENETICS INC 1.6%
Value $2.325M Shares 33,593 Est. Cost $49.37 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 1.6%
Value $2.251M Shares 26,278 Est. Cost $92.25 Unrealized -7.3%
ONC BEIGENE LTD 1.6%
Value $2.207M Shares 17,807 Est. Cost $62.64 Unrealized
ASND ASCENDIS PHARMA A S 1.5%
Value $2.111M Shares 18,334 Est. Cost $21.03 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 1.5%
Value $2.07M Shares 39,349 Est. Cost $33.00 Unrealized
SYNTHORX INC 1.4%
Value $2.041M Shares 151,048 Est. Cost $18.95 Unrealized
C CITIGROUP INC 1.4%
Value $2.027M Shares 28,938 Est. Cost $52.94 Unrealized -0.1%
CBRE CBRE GROUP INC 1.4%
Value $2.003M Shares 39,052 Est. Cost $30.82 Unrealized +61.2%
SEAGATE TECHNOLOGY PLC 1.4%
Value $1.992M Shares 42,275 Est. Cost $37.49 Unrealized
BHC BAUSCH HEALTH COS INC 1.4%
Value $1.97M Shares 78,121 Est. Cost $23.79 Unrealized -0.2%
ACA ARCOSA INC 1.4%
Value $1.967M Shares 52,264 Est. Cost $29.80 Unrealized +12.2%
KKR KKR & CO INC 1.4%
Value $1.944M Shares 76,943 Est. Cost $24.41 Unrealized -8.8%
RYTM RHYTHM PHARMACEUTICALS INC 1.3%
Value $1.897M Shares 86,208 Est. Cost $27.45 Unrealized -8.0%
MS MORGAN STANLEY 1.3%
Value $1.897M Shares 43,300 Est. Cost $31.60 Unrealized +14.8%
TRN TRINITY INDS INC 1.3%
Value $1.88M Shares 90,599 Est. Cost $16.31 Unrealized +0.9%
SLM SLM CORP 1.3%
Value $1.855M Shares 190,827 Est. Cost $11.39 Unrealized -13.0%
BFH ALLIANCE DATA SYSTEMS CORP 1.3%
Value $1.826M Shares 13,028 Est. Cost $141.80 Unrealized -24.3%
ORCHARD THERAPEUTICS PLC 1.2%
Value $1.726M Shares 123,400 Est. Cost $17.88 Unrealized
MYOVANT SCIENCES LTD 1.1%
Value $1.611M Shares 177,988 Est. Cost $12.79 Unrealized
SUMMIT MIDSTREAM PARTNERS LP 0.5%
Value $651K Shares 87,560 Est. Cost $25.15 Unrealized
HD HOME DEPOT INC 0.3%
Value $378K Shares 1,819 Est. Cost $169.54 Unrealized 0.0%
COCRYSTAL PHARMA INC 0.3%
Value $359K Shares 152,916 Est. Cost $5.95 Unrealized
SPY SPDR S&P 500 ETF TR 0.2%
Value $276K Shares 942 Est. Cost $267.76 Unrealized
IFRX INFLARX NV 0.1%
Value $185K Shares 58,449 Est. Cost $27.20 Unrealized +16.3%